Teladoc Faces Investor Investigation Following Quarterly Revenue Warning
Teladoc Health shares plummeted nearly 40 percent in late July after the company slashed its full-year revenue outlook, citing deep-seated struggles within its BetterHelp platform. The sudden downward revision has now triggered a formal investigation by the New York-based Pomerantz Law Firm into potential securities fraud.



















-min.png)


